Technical Analysis for BCT - Briacell Therapeutics Corp.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.99% | |
| Wide Bands | Range Expansion | 0.99% | |
| Narrow Range Bar | Range Contraction | 0.66% | |
| Wide Bands | Range Expansion | 0.66% | |
| Gapped Up | Strength | 0.66% | |
| Oversold Stochastic | Weakness | 0.66% | |
| Narrow Range Bar | Range Contraction | 6.23% |
Get this analysis on your stocks daily!
- Earnings date: 2024-06-10
Briacell Therapeutics Corp. Description
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company. The Company is engaged in the research and development of cancer immunotherapy technology. The Company offers BriaVax, an immunotherapy vaccine. The Company is engaged in developing and advancing its BriaVax immunotherapy vaccine for patients with advanced breast cancer. The Company is also engaged in the research and development of its companion diagnostic product, BriaDx. The Company's BriaDx program is focused on analyzing samples obtained from patients previously treated with BriaVax along with co-analysis of previously manufactured vaccine lots. The Company's analysis methods include various technologies, including gene expression profiling by Illumina microarrays and human leukocyte antigen (HLA) typing by a high-resolution method. The Company is focused on understanding the mechanism of action (MoA) of BriaVax.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Medical Specialties Therapy Oncology Immunology Antigen Immunotherapy Cancer Immunotherapy Biotechnology Companies Breast Cancer Vaccine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 10.29 |
| 52 Week Low | 2.8 |
| Average Volume | 9,535 |
| 200-Day Moving Average | 6.198 |
| 50-Day Moving Average | 3.644 |
| 20-Day Moving Average | 3.142 |
| 10-Day Moving Average | 3.005 |
| Average True Range | 0.161 |
| RSI (14) | 42.53 |
| ADX | 27.37 |
| +DI | 24.575 |
| -DI | 35.202 |
| Chandelier Exit (Long, 3 ATRs) | 3.507 |
| Chandelier Exit (Short, 3 ATRs) | 3.283 |
| Upper Bollinger Bands | 3.722 |
| Lower Bollinger Band | 2.562 |
| Percent B (%b) | 0.44 |
| BandWidth | 36.925 |
| MACD Line | -0.205 |
| MACD Signal Line | -0.244 |
| MACD Histogram | 0.0383 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.115 | ||||
| Resistance 3 (R3) | 3.120 | 3.110 | 3.108 | ||
| Resistance 2 (R2) | 3.110 | 3.099 | 3.108 | 3.105 | |
| Resistance 1 (R1) | 3.090 | 3.091 | 3.085 | 3.085 | 3.102 |
| Pivot Point | 3.080 | 3.080 | 3.078 | 3.078 | 3.080 |
| Support 1 (S1) | 3.060 | 3.069 | 3.055 | 3.055 | 3.038 |
| Support 2 (S2) | 3.050 | 3.061 | 3.048 | 3.035 | |
| Support 3 (S3) | 3.030 | 3.050 | 3.033 | ||
| Support 4 (S4) | 3.025 |
